We propose a mathematical model of the transmission dynamics of colonization by commensal bacteria within a human community subject to varying levels of antibiotic use designed to control morbidity induced by pathogenic strains of the normally commensal organisms. Colonization is assumed not to induce morbidity in the majority of cases, and antibiotic use is assumed to be related to the arrival and growth of pathogenic strains that give rise to infections including clinical symptoms of disease. In the absence of antibiotic resistance, the model shows how the pattern of antibiotic prescription and use can eliminate the non-pathogenic commensal strains from the host community if the fraction of people taking antibiotics with a de¢ned e¤cacy exceeds some critical level. The model is extended to take account of the evolution of antibiotic resistance in the commensal population. We assume resistance may be either plasmid-mediated or conferred by selection of low-level pre-existing mutants, and that resistant organisms may experience reduced reproductive ¢tness. Invasion of the host community by drug-resistant commensals is possible if certain antibiotic prescribing patterns pertain. We calculate these conditions in terms of the transmission parameter of the organism and the level of antibiotic prescription and use. The model is employed to address the issues of how best to use antibiotics in populations harbouring resistant organisms, and when resistant bacteria will out-compete sensitive strains.
I N T RO DUC T ION
The continuing spread of antibiotic resistance in a wide variety of important bacterial pathogens is a cause of concern in many regions of the world (Cohen 1992; Neu 1992; Greenwood 1995) . For some widely used antibiotics, such as beta-lactams, the steady rise in the prevalence of resistant strains is linked to increased antibiotic consumption in several countries (Baquero 1996a; Finch et al. 1996) .
More generally, however, the link between antibiotic consumption and the prevalence of resistance to a given drug has been di¤cult to establish for a variety of reasons. Foremost is the dearth of detailed longitudinal studies that combine measures of the prevalence of resistant strains (with precise de¢nitions of the term resistant) with those on the volume of drug use in a de¢ned setting, community, or country. A second issue of importance concerns the knowledge amongst public health scientists and microbiologists of the patterns of change over time in the frequency of resistance that would be predicted on the basis of an elementary knowledge of the population genetics. For example, under a constant selection pressure (i.e. a constant volume of drug use), the change overtime in the frequency of resistance will be sigmoidal in form with a very slow change following the ¢rst appearance of resistant strains, a rapid rise some years later, followed by a slow approach to an equilibrium frequency of resistance whose precise level is determined by many factors, including the magnitude of the constant selective force, the relative ¢tness of resistant versus sensitive strains, and the biological details of how resistance is conferred and transmitted between organisms.
Empirical associations between antibiotic consumption and the frequency of resistance have been observed in several recent studies, both in clinical settings (McGowan 1983; MÖller 1989; Gerding et al. 1991; Burman et al. 1992; Loulergue et al. 1994) and to a lesser extent in the community (Nissinen et al. 1995; Arason et al. 1996) . Several of these studies have provided longitudinal data charting the rise of drug resistance in speci¢c bacteria over time, although estimation of antibiotic consumption has proved to be more di¤cult to quantify precisely.
At present, few mathematical studies have examined the emergence of antibiotic resistance within frameworks that meld elements of population genetics and transmission dynamics. Massad et al. have described a hospital-based epidemiological model which addresses questions concerning the co-existence of resistant and drug-sensitive bacterial strains, but the proposed structure does not explicitly link resistance to drug consumption (Massad et al. 1993) . A variant of this model has been used to show how several antibiotics can be used in a hospital setting to minimize the rate of emergence of multi-drug resistant organisms . Recently, a simple model of the population genetics of antibiotic resistance has been developed by Levin et al. which considers the selective pressure imposed by drug treatment on a commensal bacteria (Levin et al. 1997) . In this model, a ¢xed number of hosts interact with a pool of bacteria in the environment of these hosts, where antibiotic treatment is prescribed at a de¢ned per capita rate. The model enables a relationship to be de¢ned between drug consumption and the frequency of resistance, and analyses suggest that resistant strains can persist even when resistance carries a ¢tness cost for the speci¢c levels of drug treatment.
In this paper we de¢ne an epidemiological model of the colonization of a host ( human) population by a bacterial species which normally exists as a commensal within the host and does not induce measurable morbidity. Many bacterial species typically exist as commensals in their human hosts, for example Escherichia coli, Haemophilus in£uenzae, Neisseria meningitidis, Moraxella catarrhalis, Streptococcus pneumoniae and Staphylococcus aureus, such that many people harbour colonies of the bacteria within de¢ned communities with no overt symptoms of disease. Under circumstances that are, typically, poorly understood, certain strains within these colonies may induce diseases such as otitis media and pneumonia that require antibiotic treatment. Although epidemiological data are very limited at present, it is typically assumed that the frequency of drug resistance in those`treated' infections re£ects the resistance levels pertaining in the commensal population within the host community. Treatment acts to increase their frequency in the commensal populations. Furthermore, if resistance is plasmid-mediated, its presence in commensals may result in the transmission of the attribute to more obligate pathogens (Tenover & McGowan 1996) . For this reason, a better understanding of the population genetics and transmission dynamics of resistance trends in commensal organisms under selection by antibiotic treatment is required, to improve the management of drug resistance to widely used antibiotics for the morbidity-inducing bacterial strains and species.
. T H E OR ET IC A L F R A M EWOR K
We consider a simple mathematical model in which patients experience colonization by a commensal bacterial species. Colonization may induce some morbidity, although it is assumed that treatment is not required due to an absence of clinical symptoms of infection. Antibiotic treatment is assumed to be used independently of colonization status in association with infection by other strains or species that induce morbidity.
Initially, we shall assume that patients may be classi¢ed as either susceptible S(t),colonized (infected I(t)) or receiving antibiotic treatment T(t), and that resistance is not present within the meta-population of bacteria distributed within the host population. Some patients may be taking antibiotics for other infections, and it is assumed that these individuals are prophylactically protected from colonization whilst they are undergoing treatment. New susceptibles enter the population at a rate !(t) and remain in the population for an average duration of time 1a" (for day-care centres and nursing homes 1a" will be measured in terms of months). Susceptibles become colonized at a per capita rate I(t) where is the transmission parameter (equal to the contact rate multiplied by the probability of colonization per contact) and I(t) denotes the number of colonized individuals. Colonised individuals are assumed to clear the commensal after an average duration of time of 1af .
Individuals receive treatment with antibiotics at a rate per person per unit time and enter an antibiotic treated class, T(t). They maintain treatment for an average duration of time of 1ag. Treatment is assumed to clear the commensal colonies of bacteria and protect from further colonization whilst the patient is continuing treatment. Expressing these assumptions as a set of coupled di¡erential equations gives
As a simpli¢cation, we assume that the total host population is of ¢xed size. This is a realistic approach when we wish to model the e¡ects of colonization within day-care centres, hospitals and nursing homes, where the number of places, beds or sta¡ are limiting factors. Over the time-scales of interest, a ¢xed population size is also consistent with many communities in the developed world. Since colonization confers no additional mortality, if the total population is ¢xed to, say, N, individuals, then N S(t) I(t) T(t) implying that the birth rate !(t) is simply "N. With these assumption the model simpli¢es to the following two equations and one constraint
The equations are expressed in terms of proportions: S(t) x(t)N, T(t) X(t)N and I(t) y(t)N, and the transmission parameter has been rescaled such that N. The in£uence of antibiotic consumption enters the model in both the prescribing rate and the duration of treatment 1ag. When trying to formulate policies of`best practice' in terms of minimizing the frequency of antibiotic resistance, both of these parameters are important for the design of appropriate treatment programmes.
In this, the most simple of models, the dynamics are governed entirely by the basic reproductive ratio R 0 of the commensal organism. R 0 measures the number of secondary colonizations produced in a na|« ve host population by a single colonized host (Anderson & May 1991) , and is given by
For a commensal to become established R 0 must be greater than unity. Every colonization must lead to at least one more colony. After an initial epidemic, the level of colonization will settle to an endemic equilibrium state such that the proportion susceptible is 1aR 0 and the proportion colonized is 1 À 1aR 0 .
Introducing antibiotics reduces the e¡ective duration of infectiousness since commensals are removed during treatment. Given a constant prescribing rate , the proportion p A taking antibiotics at any time is simply
Antibiotic consumption also protects people from colonization over the duration of treatment. We shall assume that protection is total, and hence only a proportion 1 À p A of individuals are either susceptible or colonized (i.e. x y 1 À p A ). Therefore, at endemic equilibrium
where * denotes an endemic state. For a commensal to become established within a community requires that y* 5 0, or equivalently that
where 0 () is a factor describing how R 0 is reduced by treatment and takes the form Figure 1 shows the variation of 0 () as a function of the prescribing rate . We assume that in the absence of treatment R 0 b 1 (i.e. the commensal is naturally present). Since 0 () is an increasing function of , eventually the prescribing rate reaches a critical rate c above which the inequality of equation (10) cannot be satis¢ed. At this point, antibiotic prescribing has removed su¤cient individuals from the susceptible class so that the commensal will be eradicated from the community. Solving the inequality gives the critical prescribing rate
where f H f " and g H g ". Substituting the critical value c into our earlier expression for the proportion taking antibiotics gives a critical proportion, p A ( c ), necessary to eradicate a commensal bacterial organism. Figure 2 shows the proportion who must take antibiotics for eradication as a function of the prevalence of colonization ( the carrier state) in the absence of treatment (1 À 1aR 0 ). As in the case of vaccination, highly transmissible commensals require a sustained e¡ort before they can be eradicated by community-based antibiotic treatment.
A N T I BIOT IC R E S I STA NC E
Drug resistance may be conveyed in bacteria by a number of biological mechanisms, such as mutation and the exchange of genetic information in the form of plasmids. In an epidemiological framework, however, it is the role antibiotic consumption plays in the onset and propagation of resistance within the environment that is the key issue. We assume the presence of a second drug-resistant strain circulating within the community. With two strains the model becomes more complex. For simplicity, we shall assume that individuals can only be colonized with a single strain, and that if colonized by resistant organisms, then antibiotics may either have no e¡ect or select for pre-existing resistant mutants. Furthermore, we assume that hosts colonized with resistant bacteria can transmit plasmids which confer resistance to sensitively colonized hosts. These assumptions require two additional classes: (i) hosts that are colonized by the resistant strain (z)) and (ii) hosts that are colonized by the resistant strain and taking antibiotics (Z(t)). Figure 3 shows a representation of the expanded model. With the same constant population size as in the simple model, the full equations are
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All parameters have the same de¢nitions as in the simple model. Resistant strains have their own transmission parameter, H , and duration of colonization, 1af
H , which may or may not be the same as sensitive strains. Furthermore, we assume a proportion ' of individuals who are sensitively colonized will select pre-existing antibiotic-resistant mutants once they undergo treatment. Plasmid transfer is measured by the transmission parameter, $ which is analogous to H , equal to the contact rate between hosts multiplied by the probability that the plasmid is transferred between hosts (c.f.
H which is measured by the contact rate multiplied by the probability of colonization). If during a single contact, colonization and plasmid transfer are equally likely, then $ is equal to H . In general, we might expect that more plasmid-bearing organisms are required to transfer resistance to sensitively colonized hosts compared to the colonization of commensal-free hosts (i.e.
H b $). When antibiotics were ¢rst introduced to treat bacterial infections the bacterial populations were thought to be totally susceptible. One explanation for this is that in the absence of drug selection pressures, drug-resistant organisms experience some form of ¢tness cost (Frank 1996) . In this framework, we introduce a ¢tness cost in the form of a reduced basic reproductive ratio for the resistant strain, i.e.
Where two strains are competing for resources (in this case hosts to colonize) classical ecological theory predicts that the strain with the highest R 0 will outcompete the other strains. Na|« vely, we might therefore predict that in the absence of selection, the resistant strain will be eliminated from the community. Antibiotic treatment can either upset the balance in reproductive ratios such that the resistant strain gains the advantage, or it can create a niche of treated hosts who can be resistantly colonized overcoming the competition. Introducing mutation and plasmid transfer can further overcome the competition between strains and stabilize coexistence between drug-sensitive and drug-resistant strains which otherwise might not be possible.
. DY NA M IC S
The dynamics of the full model are much more complex than the simple framework without resistance. and maybe colonized by either sensitive (y) or resistant bacteria (z and Z). In addition, individuals are prescribed antibiotics at a rate and enter either a treated susceptible class (X) or treated resistant class (Z) depending upon their colonization status. Resistance can be conferred by either (i) selection of resistant mutants during treatment ( y 3 Z) or (ii) plasmid transfer from resistantly colonized hosts ( y 3 z). Following the introduction of treatment, a proportion p A X(t) Z(t) are being treated with antibiotics at all times.
In the absence of any drug-resistant strains ( 0) the dynamics remain unchanged from the simple model (equations (4)^(11)). The overall dynamics are determined by the basic reproductive ratios R 0 and R H 0 , which we shall assume are greater than unity (otherwise the commensal will never become established). Including resistance allows for the possibility of invasion by a resistant strain, and the full model framework allows us to address issues of whether resistance will enter a community and whether once present it will come to dominate over sensitive strains.
We know from the simple model that a community can withstand invasion by drug-sensitive commensals provided that the antibiotic prescribing rate is greater than the critical rate c (equation (12)). Furthermore, in the absence of drug-sensitive colonization, everyone remains susceptible to drug-resistant strains, regardless of antibiotic treatment. Provided that the resistant strains can be independently transmitted (i.e. R H 0 b 1), then the community will become colonized. Questions remain, however, about whether a community which is subject to entirely resistant colonization can be replaced by a sensitive commensal, and what changes in treatment patterns are required to achieve this.
Q 1 is the same endemic state as the simple model prior to the introduction of resistance, and is given by equation (9). We have already shown that increased prescribing will lead to the eventual removal of sensitive colonization once the prescribing rate exceeds c . Whether a resistant strain will invade a community depends upon the exact assumptions regarding the transmission of drug resistance. Ignoring the two resistance mechanisms (mutation and plasmid transfer), an uncolonized community will be susceptible to drugresistant commensals provided that a su¤cient proportion of the community remain susceptible to colonization (i.e. in classes x and X). Equivalently the reproductive ratio for the resistant strains must satisfy
where R s 0 is the critical reproductive ratio necessary for drug-resistant commensals to invade a drugsensitive colonized community, and is given by
Since R s 0 is greater than unity, colonization of a community by drug-sensitive commensals can protect a community from invasion by drug-resistant commensals provided that the level of antibiotic consumption remains below a critical threshold.
If antibiotic treatment selects for pre-existing drugresistant mutants (' T 0), then the very action of introducing treatment will always give rise to resistant colonization of some members of a community, and hence coexisistence. Plasmid-mediated drug resistance allows uncolonized hosts to acquire resistance by direct transmission, and drug-sensitive colonized hosts by the acquisition of genetic information from other resistantly colonized hosts. There is therefore an increase in the proportion of hosts that remain susceptible to colonization by drug-resistant strains, such that the critical reproductive ratio R s 0 is reduced to
R HH 0 is the reproductive ratio of the plasmid which mediates resistance and is an independent measure of resistance transmission. In common with the reproductive ratio R H 0 , the plasmid reproductive ratio is of the form
and can be de¢ned as the average number of secondary hosts`infected' with the plasmid by a single plasmidbearing host when introduced to a wholly colonized plasmid-free community. If the plasmid is truly independently transmissible (as might be the case for bacterial viruses), then we would expect R HH 0 to be greater than one. If, however, R HH 0 y* b 1 then equation (22) implies that drug resistance will always become established within a community due to plasmidmediated spread rather than direct transmission of drug-resistant bacteria, irrespective of issues of transmission ¢tness cost. Introducing plasmid transfer has in e¡ect decoupled the transmission of bacteria from the population genetics of plasmid transfer. How plasmids can become stabilized within a community will be dealt with in greater detail elsewhere (Austin & Anderson 1997b ).
(c) Resistant colonization Q 2 (x*,X*,0,z*,Z*) If drug-resistant bacteria are introduced into an uncolonized community, or have a transmission ¢tness advantage (which may be induced by antibiotic treatment), then the system will evolve towards ¢xation (Q 2 ). Since we have assumed that antibiotic prescribing is independent of colonization status, the proportion colonized by drug-resistant commensals will be 1 À 1aR H 0 , and the proportion treated with antibiotics will be p A . Therefore, once drug resistance has reached ¢xation, the endemic state Q 2 will be given by
Drug-resistant commensals will persist provided that the drug-sensitive strain cannot reinvade. Neglecting mutation and plasmid-mediated resistance mechanisms, the drug-resistant strain will cease to Population dynamics of antibiotic resistance D. J. Austin and others 1633 remain endemic provided that the reproductive ratio of the drug-sensitive invading strain satis¢es
Comparing this expression with equation (11) we see that once a drug-resistant commensal has reached ¢xa-tion, it will be R H 0 times harder for it to be disturbed by a drug-sensitive strain. This is a further example of how prior colonization by one form of commensal can protect a community against other forms. If the drugsensitive strain has only a slight transmission ¢tness advantage over the resistant strain, reintroducing the drug-sensitive strain once ¢xation has been reached may require a reduction in 0 () via a reduced prescribing rate, . Conversely, if the drug-resistant strain has a ¢tness advantage (R H 0 b R 0 ), then the sensitive strain cannot be reintroduced.
Selecting pre-existing drug-resistant mutants by antibiotic treatment has little e¡ect on levels of drugresistance once ¢xation has been reached. However, the action of plasmid-mediated drug-resistance will serve to make the ¢xation of drug resistance more stable because it provides an independent way in which drug-sensitive commensals can be replaced by drug-resistant ones (see Appendix 1).
(d) Coexistence Q 3 (x*,X*, y*,z*,Z*)
In many instances where drug resistance has been identi¢ed, its identi¢cation has led neither to eradication (Q 1 ) nor ¢xation (Q 2 ), but to a state of coexistence where both drug-sensitive and drug-resistant commensals circulate within a host community. Exact calculation of the full endemic equilibrium is given in Appendix 1. Establishing the stability of coexistence is very di¤cult, however we can gain an intuitive idea, given that we require that both singly colonized endemic states be unstable to invasion (¢gure 4). In the absence of mutation (which can always stabilize coexistence) and plasmid transfer, stable coexistence of sensitive and resistant commensals requires that the reproductive ratio for the drug-resistant strain lies in the range
where R r 0 is given by R 0 a 0 () (equation (25) Where a high proportion of the population are being treated with antibiotics (such as in hospitals) we would expect the duration of the stay to be approximately equal to the time between treatments (i.e. 9 "). This makes the coexistence region larger (all other parameters remaining equal) suggesting that coexistence between drug-sensitive and resistant strains will be more likely in clinical settings compared to areas with lower antibiotic usage, such as day-care centres and nursing homes.
Mutation imparts a natural coexistence to the system which can overcome all aspects of competition for susceptible hosts provided that antibiotic treatment is maintained (typically * 9 'y*). If the basic reproductive ratio R H 0 , lies below R r 0 then drug resistance will not reach ¢xation, and the level of resistance will be determined by both the antibiotic prescribing rate and the proportion of treated hosts that select drugresistant commensals. Plasmid-mediated resistance again requires R The emergence of antibiotic resistance may occur gradually over time even under conditions of a constant antibiotic selection pressure. Selection of resistance can take place in the absence of changes in prescribing practice. In ¢gure 6, we show how a highly prevalent commensal (R 0 10) can successfully be selected for by intense antibiotic treatment within a community. In this example, the use of antibiotics prior to the introduction of resistance has reduced the prevalence from an expected 90% to 77%. Antibiotics are prescribed at a constant rate of once every three months for ten days (p A 9 10%), which would not be unusual in the close con¢nes of a nursing home or day-care centre. After introduction, resistance takes about ¢ve years to reach an equilibrium frequency of 72% of those colonized. Increasing R H 0 for the resistant strain will increase both the proportion of resistant cases (eventually leading to ¢xation), and the rate of emergence.
When antibiotic resistance is introduced into a community (or develops through mutation or plasmid transfer), whether it will subside, stabilize, or reach ¢xation depends both on the relative transmission ¢tness of the resistant strain (R H 0 aR 0 ) and the antibiotic prescribing rate (). Figure 7 shows the endemic proportion of hosts colonized with resistant bacteria,
as a function of the prescribing rate. For simplicity, we have ignored mutation and plasmid transfer, and in doing so observe a threshold prescribing rate above which resistance becomes established, leading to ¢xation when antibiotics are prescribed extensively. Increasing R 0 will lead to an increased threshold prescribing rate and a much steeper transition to ¢xa-tion. Increasing R H 0 (i.e. increasing transmission ¢tness) reduces the threshold. Commensals which are more prevalent, and therefore have greater transmission potential, or experience a high transmission ¢tness cost, can withstand higher prescribing rates without being eliminated from the host population, primarily because they have colonized extensively, reducing the niche available for the drug-resistant strains.
Using the endemic proportion that are carriers of antibiotic resistant strains as a measure, we can look at the e¡ect of using di¡erent treatment pro¢les. For example, what are the relative e¡ects on resistance of short intensive treatments administered to most infected people compared with longer treatments given to fewer individuals? Furthermore, what e¡ect does transmissibility (R 0 ) have on resistance for a given level of antibiotic consumption? Figure 8 addresses these questions in the absence of mutation and plasmid-mediated resistance mechanisms. In Figure 8a , we show the variation of p R with prescribing rate and treatment duration 1ag and ¢xed R 0 (R 0 10 is equivalent to nine persons in ten being colonized). There is a clear trade-o¡ between prescribing rate and duration of treatment. As expected, when resistance is present, it is minimized using shorter treatments for a given prescribing rate. Figure 8b shows the variation of p R with prevalence and the proportion taking antibiotics, p A .Where colonization is extensive (high R 0 values), antibiotics can be used with less risk of resistance. However, when colonization is at low levels (i.e. low R 0 values) the appearance and establishment of resistance is a much greater problem. table 1 and no mutation of plasmid transfer is included. Increasing the prescribing rate above a threshold of 0.2 per month leads to the emergence of resistance which reaches ¢xation. Increasing R 0 shifts the curve to higher prescribing rates and makes the transition more rapid. Increasing the transmission ¢tness reduces the threshold prescribing rate. Highly prevalent commensals which experience a large transmission ¢tness cost for resistance can withstand antibiotic selection much more e¡ectively than less prevalent ones.
DI S C U S S ION
We have described a simple epidemiological model of the colonization of a population by commensal bacteria. By introducing antibiotic consumption into the model and assuming that individuals receive treatment for infections independent of their commensal £ora, we are able to study the relationship between antibiotic consumption and colonization. A commensal is able to colonize a community if its basic reproductive ratio R 0 , de¢ned as the number of secondary individuals who are colonized when a single carrier enters a na|« ve community, is greater than unity. Since the endemic prevalence is simply 1 À 1aR 0 , estimates suggest R 0 values of approximately 1^10 for many of the common commensal bacteria of human communities. We assume that when an individual is prescribed antibiotics, both the pathogen and any drug-sensitive commensals are cleared. The implication from this assumption is that those who are taking antibiotics are protected from colonization by drug-sensitive commensals during the course of treatment.Therefore, if antibiotic consumption is su¤-ciently high, a commensal can be eradicated from a population when the prescribing rate exceeds some critical level (or, equivalently, when a critical proportion are taking antibiotics at any one time).This result may be of practical signi¢cance in infection control in hospitals where antibiotics are frequently administered prophylactically.
We have assumed that drug-resistant implies wholly resistant, and therefore, individuals who are taking antibiotics remain susceptible to colonization by drugresistant commensals. This can create a niche for resistant strains, although the trait of resistance may be subject to some ¢tness cost. We examine two mechanisms by which resistance can be transferred between hosts, namely the selection of pre-existing mutants during treatment and the transfer of genetic material via plasmids to sensitively colonized hosts. The selection of pre-existing mutants will always give rise to resistance once new drugs are introduced, and lead to ¢xation given su¤ciently high drug usage. Plasmidmediated resistance provides the opportunity for resistance to be conveyed independently, thereby increasing the proportion of hosts that are susceptible to drug resistance. We have shown that if the plasmid is su¤-ciently transmissible, then the trait of drug resistance can be maintained solely by plasmid transfer, even in the absence of drug selection pressures. This provides one explanation of the very rapid onset of resistance sometimes seen when new drugs are introduced. If the plasmid is not su¤ciently transmissible in its own right (R HH 0`1 ), then we predict that if antibiotic consumption remains below a threshold level (either as the prescribing rate or the proportion taking antibiotics), then a resistant strain will not be able to establish within the host community.
The exact nature of the ¢tness cost for most drugresistant bacteria is unknown with respect to impact on transmission success. However, reduced transmissibility is the most probable e¡ect, although in some cases resistance may carry no costs at all. Where there is no ¢tness cost we predict that under antibiotic selection pressure drug-resistant commensals will reach ¢xation and completely replace sensitive commensals. Furthermore, there will be no opportunity to return to drug sensitivity. If resistance is associated with a ¢tness cost (perhaps the plasmid codes for other traits which reduce transmission), then selection pressures may under some prescribing practices lead either to no resistance being present, or stable coexistence between sensitive and resistant strains.
The existence of a threshold antibiotic prescribing rate, both to eradicate a commensal and to prevent the emergence of resistance, suggests that maintaining a population free of a single resistance mechanism can be achieved by restricting or controlling the communitywide antibiotic consumption rate. Once antibiotic resistance has become established, the most pressing questions are those concerning its control and, perhaps, its eradication. Our results suggest that once resistance has reached ¢xation, a return to coexisting or drugsensitive colonizations is much harder to achieve and will require changes in prescribing practice. Some surveys of resistant organisms (albeit typically based on samples from clinical settings) have shown coexistence of drug-resistant and sensitive strains (Nissinen et al. 1995) . There is a trade-o¡ between prescribing rate and treatment duration such that short courses can be given more frequently than long courses. Highly prevalent commensals provide a form of herd immunity to resistance so that a greater proportion of people can take antibiotics for a given level of resistance.
antibiotic with a di¡erent resistance mechanism) will generally lead to the gradual, though often not complete, removal of a drug-resistant commensal. The rate of removal will, however, typically be much slower than that of emergence and, if not completely removed, drugresistant commensals will ascend once treatment is restarted (Levin et al. 1997) .
The model presented here makes few assumptions other than commensal colonization takes place and may not induce morbidity, and antibiotic consumption is independent of colonization. To apply the model to speci¢c cases of the emergence of resistance in hospital or other settings, we require estimates of prevalence (R 0 ), duration of colonization (1af ), antibiotic prescribing rate () and duration of treatment (1ag). Although exact data regarding prevalence and duration of colonization are scarce, the increasing awareness of the threat of resistance has given rise to greater numbers of studies in recent years. Antibiotic consumption data are now being made available through marketing databases worldwide (Baquero 1996b ) which measure consumption as de¢ned daily doses (DDDs). The DDD gives an estimate of the proportion of people taking antibiotics, although this may not be broken down into epidemiologically relevant classes (e.g. children, adults less than 65 years old and adults more than 65 years old). Applying this model, we show in another paper how the rise in Moraxella catarrhalis in Finnish children can be accurately predicted given the necessary resistance and consumption data (Austin et al. 1998) .
A return to the days of fully antibiotic-susceptible pathogens and the eradication of drug resistance is of course unlikely. Certainly reductions in resistance levels are possible and have been seen in clinical settings when antibiotic prescribing patterns are changed (i.e. di¡erent compounds and di¡erent levels of consumption) (Barber et al. 1960) . Within the community, however, the options available are less easily implemented without government legislation to provide options on the type and volume of drug use in whole communities or large aggregations of people. Patients with community-acquired infections have expectations of antibiotic therapy which have in the past been met with e¡ective treatment. The blanket prescribing policies of the past will cease to maintain that e¡ectiveness in the future. more transmissible than the plasmid (R H 0 b R HH 0 ). The stability of ¢xation (Q 2 ) is again established by requiring that dyadt b 0, and implies that a drugsensitive commensal can be reintroduced into a resistantly colonized host population when
Again this is greater than is required for introduction to an uncolonized population, suggesting that once ¢xation has been reached, it will be di¤cult to return to drug-sensitive colonization.
